axoCells™ Human iPSC-Derived Ventricular Cardiomyocytes, male donor, ≥1 million cells

axoCells Human iPSC-Derived Ventricular Cardiomyocytes (≥1 million cells) for cardiovascular research. Ventricular cardiomyocytes made from iPSCs generated from a 74-year-old male donor's pulmonary fibroblasts.

Key highlights include:

• Spontaneously beat 3 days post-thaw and assay-ready in just 7 days
• Validated against all 28 CiPA compounds
• Demonstrate functional responses in a range of assay formats including patch clamp, electrophysiology, and voltage-sensitive dyes

They are frequently used to fuel in vitro cardiotoxicity models to assess drug safety and for cardiac research. They can also be used in co-culture with other cells (including atrial cardiomyocytes).